Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction.
Pinzon-Charry A, Schmidt CW, López JA
Breast Cancer Res 2006, 8:402
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
Kaneno R, Shurin GV, Tourkova IL, Shurin MR
Journal of Translational Medicine 2009, 7:58 (10 July 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Research article    
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
Esteva FJ, Wang J, Lin F, Mejia JA, Yan K, Altundag K, Valero V, Buzdar AU, Hortobagyi GN, Symmans WF, Pusztai L
Breast Cancer Research 2007, 9:R87 (17 December 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] [1 comment]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.